medsynapse-hcp
Introduction Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease characterized by painful abscesses, nodules, and draining tunnels, often leading to morbidity, scarring, and reduced quality of life (1). Treatment options remain limited, particularly in biologic-naïve moderate-to-severe disease (1). Adalimumab (anti-TNF) is approved
Dual TNF/OX40L Inhibition with Brivekimig in Moderate-to-Severe Hidradenitis Suppurativa: Synopsis of the HS-OBTAIN Phase 2a Trial

Dual TNF/OX40L Inhibition with Brivekimig in Moderate-to-Severe Hidradenitis Suppurativa: Synopsis of the HS-OBTAIN Phase 2a Trial

59 Reached1 Comments

Similar Content

Woman presented with Fever of Unknown Origin
Woman presented with Fever of Unknown Origin
7725 Reached93 Comments19 Likes
<p>How Physicians Should Manage Stress?</p>

How Physicians Should Manage Stress?

35294 Reached152 Comments203 Likes
Rubella Syndrome in Neonate
Rubella Syndrome in Neonate
1400 Reached12 Comments9 Likes
Pregnant Woman with HIV-1 Infection
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes
<p>Use of Clindamycin for Managing Bacterial Vaginosis</p>

Use of Clindamycin for Managing Bacterial Vaginosis

11195 Reached29 Comments8 Likes